Chicago Partners Investment Group LLC Dexcom Inc Transaction History

Chicago Partners Investment Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$67.99 - $132.89 $48,000 - $93,820	-706 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$94.08 - $130.2 $2,257 - $3,124	-24 Reduced 3.29%	706 $218,000
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $3,246 - $4,070	25 Added 3.55%	730 $297,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $2,454 - $3,293	23 Added 3.37%	705 $96,000
Q2 2021 Aug 02, 2021	SELL	$80.99 - $107.93 $5,993 - $7,986	-74 Reduced 9.79%	682 $309,000
Q1 2021 Apr 28, 2021	SELL	$84.79 - $104.74 $2,034 - $2,513	-24 Reduced 3.08%	756 $317,000
Q4 2020 Jan 27, 2021	BUY	$78.0 - $104.5 $1,872 - $2,508	24 Added 3.17%	780 $289,000
Q3 2020 Nov 06, 2020	SELL	$95.51 - $112.95 $4,393 - $5,195	-46 Reduced 5.74%	756 $251,000
Q2 2020 Jul 31, 2020	BUY	$62.68 - $105.34 $7,208 - $12,114	115 Added 16.74%	802 $340,000
Q1 2020 Apr 22, 2020	BUY	$47.79 - $75.63 $32,831 - $51,957	687 New	687 $222,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.